Role Faculty Location Zuckerberg San Francisco General Hospital Category Clinical Publications Single Tri-Epitopic Antibodies (TeAbs) to Botulinum Neurotoxin Serotypes B, E, and F Recapitulate the Full Potency of a Combination of Three Monoclonal Antibodies in Toxin Neutralization. Lou J, Wen WH, Conrad F, Tam CC, Garcia-Rodriguez C, Farr-Jones S, Marks JD Toxins . Jun 4, 2025 Dynamic allostery drives autocrine and paracrine TGF-ß signaling. Jin M, Seed RI, Cai G, Shing T, Wang L, Ito S, Cormier A, Wankowicz SA, Jespersen JM, Baron JL, Carey ND, Campbell MG, Yu Z, Tang PK, Cossio P, Wen W, Lou J, Marks J, Nishimura SL, Cheng Y Cell . Sep 12, 2024 A Three-Monoclonal Antibody Combination Potently Neutralizes BoNT/G Toxin in Mice. Fan Y, Lou J, Tam CC, Wen W, Conrad F, Leal da Silva Alves P, Cheng LW, Garcia-Rodriguez C, Farr-Jones S, Marks JD Toxins . Apr 30, 2023 Multicolor fluorescence activated cell sorting to generate humanized monoclonal antibody binding seven subtypes of BoNT/F. Fan Y, Sun Z, Conrad F, Wen W, Zhao L, Lou J, Zhou Y, Farr-Jones S, Marks JD PloS one . Sep 1, 2022 A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D. Garcia-Rodriguez C, Yan S, Geren IN, Knopp KA, Dong J, Sun Z, Lou J, Conrad F, Wen WH, Farr-Jones S, Smith TJ, Brown JL, Skerry JC, Smith LA, Marks JD Toxins . Sep 10, 2021 A tumor-specific mechanism of Treg enrichment mediated by the integrin αvβ8. Seed RI, Kobayashi K, Ito S, Takasaka N, Cormier A, Jespersen JM, Publicover J, Trilok S, Combes AJ, Chew NW, Chapman J, Krummel MF, Lou J, Marks J, Cheng Y, Baron JL, Nishimura SL Science immunology . Mar 26, 2021 Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β. Campbell MG, Cormier A, Ito S, Seed RI, Bondesson AJ, Lou J, Marks JD, Baron JL, Cheng Y, Nishimura SL Cell . Jan 16, 2020 The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA. Fan Y, Barash JR, Conrad F, Lou J, Tam C, Cheng LW, Arnon SS, Marks JD Toxins . Dec 20, 2019 Structural Studies avß8 Integrin by Single Particle Cryo-EM. Melody G. Campbell, Anthony Cormier, Saburo Ito, Shenping Wu, Jianlong Lou, James Marks, Jody L. Baron, Stephen L. Nishimura, Yifan Cheng Microscopy and Microanalysis . Aug 1, 2019 Botulinum Neurotoxins (BoNTs)-Antibody and Vaccine. Lou J, Marks JD Toxins . Nov 26, 2018 Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells. Takasaka N, Seed RI, Cormier A, Bondesson AJ, Lou J, Elattma A, Ito S, Yanagisawa H, Hashimoto M, Ma R, Levine MD, Publicover J, Potts R, Jespersen JM, Campbell MG, Conrad F, Marks JD, Cheng Y, Baron JL, Nishimura SL JCI Insight . Oct 18, 2018 Cryo-EM structure of the αvβ8 integrin reveals a mechanism for stabilizing integrin extension. Cormier A, Campbell MG, Ito S, Wu S, Lou J, Marks J, Baron JL, Nishimura SL, Cheng Y Nature structural & molecular biology . Jul 30, 2018 A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes. Garcia-Rodriguez C, Razai A, Geren IN, Lou J, Conrad F, Wen WH, Farr-Jones S, Smith TJ, Brown JL, Skerry JC, Smith LA, Marks JD Toxins . Mar 1, 2018 A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A. Lou J, Wen W, Conrad F, Meng Q, Dong J, Sun Z, Garcia-Rodriguez C, Farr-Jones S, Cheng LW, Henderson TD, Brown JL, Smith TJ, Smith LA, Cormier A, Marks JD Toxins . Feb 15, 2018 A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes. Fan Y, Garcia-Rodriguez C, Lou J, Wen W, Conrad F, Zhai W, Smith TJ, Smith LA, Marks JD PloS one . Mar 21, 2017 Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H. Fan Y, Barash JR, Lou J, Conrad F, Marks JD, Arnon SS The Journal of infectious diseases . Mar 1, 2016 Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B. Fan Y, Dong J, Lou J, Wen W, Conrad F, Geren IN, Garcia-Rodriguez C, Smith TJ, Smith LA, Ho M, Pires-Alves M, Wilson BA, Marks JD Toxins . Aug 26, 2015 Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity. Fan Y, Geren IN, Dong J, Lou J, Wen W, Conrad F, Smith TJ, Smith LA, Ho M, Pires-Alves M, Wilson BA, Marks JD PloS one . Aug 14, 2015 TGF-β-Dependent Dendritic Cell Chemokinesis in Murine Models of Airway Disease. Hashimoto M, Yanagisawa H, Minagawa S, Sen D, Ma R, Murray LA, Tsui P, Lou J, Marks JD, Baron JL, Krummel MF, Nishimura SL Journal of immunology (Baltimore, Md. : 1950) . Jun 24, 2015 Transforming Growth Factor-β and Interleukin-1β Signaling Pathways Converge on the Chemokine CCL20 Promoter. Brand OJ, Somanath S, Moermans C, Yanagisawa H, Hashimoto M, Cambier S, Markovics J, Bondesson AJ, Hill A, Jablons D, Wolters P, Lou J, Marks JD, Baron JL, Nishimura SL The Journal of biological chemistry . Apr 27, 2015 131. Human antibody engineering for prevention and treatment of botulinum neurotoxin (BoNT) intoxication. Jianlong Lou, Consuelo Garcia-Rodriguez, Yongfeng Fan, Jianbo Dong, Weihua Wen, Fraser Conrad, Gabriel Manzanarez, Margarita Sanchez, James D. Marks Toxicon . Jan 1, 2015 Development of an ELISA microarray assay for the sensitive and simultaneous detection of ten biodefense toxins. Jenko KL, Zhang Y, Kostenko Y, Fan Y, Garcia-Rodriguez C, Lou J, Marks JD, Varnum SM The Analyst . Aug 12, 2014 Selective targeting of TGF-β activation to treat fibroinflammatory airway disease. Minagawa S, Lou J, Seed RI, Cormier A, Wu S, Cheng Y, Murray L, Tsui P, Connor J, Herbst R, Govaerts C, Barker T, Cambier S, Yanagisawa H, Goodsell A, Hashimoto M, Brand OJ, Cheng R, Ma R, McKnelly KJ, Wen W, Hill A, Jablons D, Wolters P, Kitamura H, Araya J, Barczak AJ, Erle DJ, Reichardt LF, Marks JD, Baron JL, Nishimura SL Science Translational Medicine . Jun 18, 2014 Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A. Strotmeier J, Mahrhold S, Krez N, Janzen C, Lou J, Marks JD, Binz T, Rummel A FEBS letters . Feb 25, 2014 RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxin. Janardhanan P, Mello CM, Singh BR, Lou J, Marks JD, Cai S Talanta . Sep 13, 2013 Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E. Mahrhold S, Strotmeier J, Garcia-Rodriguez C, Lou J, Marks JD, Rummel A, Binz T The Biochemical journal . Jul 1, 2013 Comparison of neutralizing abilities of human monoclonal antibodies binding different epitopes on botulinum neurotoxin A. Z. Sun, J. Lou, L. Cheng, T.J. Smith, J. Dong, W. Wen, F. Conrad, C. Garcia, Y. Fan, T. Henderson, J. Brown, J. Skerry, L.A. Smith, T. Harrison, A. D'Andrea, M. Tomic, J.D. Marks Toxicon . Jun 1, 2013 Development of an ELISA microarray platform for the sensitive and quantitative detection of botulinum neurotoxins. Y. Zhang, J. Lou, J.D. Marks, K. Jenko, S. Varnum Toxicon . Jun 1, 2013 Generation, expression and purification of monoclonal-antibody-specific engineered domains to support development of oligoclonal recombinant antitoxins against BoNT/B and BoNT/E. Q. Meng, C. Garcia, M. Silberg, G. Manzanarez, J. Lou, Y. Fan, F. Conrad, M. Li, J. Freeberg, J. Bettencourt, T. Breece, X. Pan, J. Ma, B. To, C. Obi, M.T. Tomic, J.D. Marks Toxicon . Jun 1, 2013 Human monoclonal antibodies binding botulinum neurotoxin types C, D, and mosaic neurotoxins C-D and D-C. C. Garcia, S. Yan, I. Geren, J. Lou, W. Wen, F. Conrad, T.J. Smith, J. Brown, J. Skerry, L.A. Smith, J.D. Marks Toxicon . Jun 1, 2013 Monoclonal antibodies against botulinum neurotoxin serotype F. Y. Fan, J. Lou, C. Garcia, W. Zhai, J. Dong, W. Wen, F. Conrad, J. Brown, J. Skerry, T.J. Smith, L.A. Smith, J.D. Marks Toxicon . Jun 1, 2013 Quantification of botulinum neurotoxin in intoxicated neurons. K. Bagramyan, D.V. Trinh, J. Lou, Z. Sun, J.D. Marks, M. Kalkum Toxicon . Jun 1, 2013 Recombinant monoclonal-antibody-based antitoxins for treatment of types A, B, and E botulism. M. Tomic, C. Garcia, J. Lou, I.N. Geren, Q. Meng, F. Conrad, W. Wen, T.J. Smith, J. Brown, L.A. Smith, A. Wajid, A.C. Dadson, A.H. Horwitz, J. Freeberg, J.D. Marks Toxicon . Jun 1, 2013 Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays. Zhang Y, Lou J, Jenko KL, Marks JD, Varnum SM Analytical biochemistry . Aug 27, 2012 Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies. Zhou Y, Goenaga AL, Harms BD, Zou H, Lou J, Conrad F, Adams GP, Schoeberl B, Nielsen UB, Marks JD Molecular cancer therapeutics . May 7, 2012 Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies. Kalb SR, Santana WI, Geren IN, Garcia-Rodriguez C, Lou J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR BMC biochemistry . Nov 15, 2011 Affinity maturation to improve human monoclonal antibody neutralization potency and breadth against hepatitis C virus. Wang Y, Keck ZY, Saha A, Xia J, Conrad F, Lou J, Eckart M, Marks JD, Foung SKH The Journal of biological chemistry . Oct 14, 2011 Antibodies that bind integrin Alpha-V Beta-8 Stephen Nishimura, Jianlong Lou, Jody Lynn Baron, James D Marks Antibodies that bind integrin Alpha-V Beta-8 . Aug 17, 2011 Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β. Kitamura H, Cambier S, Somanath S, Barker T, Minagawa S, Markovics J, Goodsell A, Publicover J, Reichardt L, Jablons D, Wolters P, Hill A, Marks JD, Lou J, Pittet JF, Gauldie J, Baron JL, Nishimura SL The Journal of clinical investigation . Jun 6, 2011 Response re: 'Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin' by Garcia-Rodriguez et al., PEDS, 2011;24:321-331. Garcia-Rodriguez C, Geren IN, Lou J, Conrad F, Forsyth C, Wen W, Chakraborti S, Zao H, Manzanarez G, Smith TJ, Brown J, Tepp WH, Liu N, Wijesuriya S, Tomic MT, Johnson EA, Smith LA, Marks JD Protein engineering, design & selection : PEDS . Apr 18, 2011 Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors. Rudnick SI, Lou J, Shaller CC, Tang Y, Klein-Szanto AJ, Weiner LM, Marks JD, Adams GP Cancer research . Mar 15, 2011 INTEGRIN αVβ8 NEUTRALIZING ANTIBODY Stephen Nishimura, Jianlong Lou, Jody Lynn Baron, James D Marks INTEGRIN αVβ8 NEUTRALIZING ANTIBODY . Dec 30, 2010 Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Garcia-Rodriguez C, Geren IN, Lou J, Conrad F, Forsyth C, Wen W, Chakraborti S, Zao H, Manzanarez G, Smith TJ, Brown J, Tepp WH, Liu N, Wijesuriya S, Tomic MT, Johnson EA, Smith LA, Marks JD Protein engineering, design & selection : PEDS . Dec 13, 2010 Anti-Botulinum Neurotoxin Antibodies James D. Marks, Jianbo Dong, Jianlong Lou Anti-Botulinum Neurotoxin Antibodies . Oct 19, 2010 Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. Kalb SR, Garcia-Rodriguez C, Lou J, Baudys J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR PloS one . Aug 17, 2010 THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS James D Marks, Isin Geren, Maria Consuelo Garcia, Jianlong Lou, Ali Razai THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS . Jul 1, 2010 THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS James D Marks, Isin Geren, Jianlong Lou THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS . Apr 20, 2010 Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating. Lou J, Geren I, Garcia-Rodriguez C, Forsyth CM, Wen W, Knopp K, Brown J, Smith T, Smith LA, Marks JD Protein engineering, design & selection : PEDS . Feb 15, 2010 Tumor detection by imaging proteolytic activity. Darragh MR, Schneider EL, Lou J, Phojanakong PJ, Farady CJ, Marks JD, Hann BC, Craik CS Cancer research . Feb 9, 2010 A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region. Dong J, Thompson AA, Fan Y, Lou J, Conrad F, Ho M, Pires-Alves M, Wilson BA, Stevens RC, Marks JD Journal of molecular biology . Feb 6, 2010 Affinity Maturation by Chain Shuffling and Site Directed Mutagenesis. Jianlong Lou, James D. Marks Antibody Engineering . Jan 1, 2010 Antibody protection against botulinum neurotoxin intoxication in mice. Cheng LW, Stanker LH, Henderson TD, Lou J, Marks JD Infection and immunity . Aug 3, 2009 Rapid multiplexed flow cytometric assay for botulinum neurotoxin detection using an automated fluidic microbead-trapping flow cell for enhanced sensitivity. Ozanich RM, Bruckner-Lea CJ, Warner MG, Miller K, Antolick KC, Marks JD, Lou J, Grate JW Analytical chemistry . Jul 15, 2009 Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies. Warner MG, Grate JW, Tyler A, Ozanich RM, Miller KD, Lou J, Marks JD, Bruckner-Lea CJ Biosensors & bioelectronics . Jun 26, 2009 Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. Kalb SR, Lou J, Garcia-Rodriguez C, Geren IN, Smith TJ, Moura H, Marks JD, Smith LA, Pirkle JL, Barr JR PloS one . Apr 28, 2009 Renewable surface fluorescence sandwich immunoassay biosensor for rapid sensitive botulinum toxin detection in an automated fluidic format. Grate JW, Warner MG, Ozanich RM, Miller KD, Colburn HA, Dockendorff B, Antolick KC, Anheier NC, Lind MA, Lou J, Marks JD, Bruckner-Lea CJ The Analyst . Mar 5, 2009 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins Marks James D; Geren Isin N; Garcia Maria Consuelo; Lou Jianlong; Razai Ali. THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS . Jan 15, 2009 The use of Endopep-MS to detect multiple subtypes of botulinum neurotoxins A, B, E, and F. Suzanne R. Kalb, Theresa J. Smith, Hercules Moura, Karen Hill, Jianlong Lou, Isin N. Geren, Consuelo Garcia-Rodriguez, James D. Marks, Leonard A. Smith, James L. Pirkle, John R. Barr International Journal of Mass Spectrometry . Dec 1, 2008 Development of human single-chain antibodies against SARS-associated coronavirus. Leung KM, Feng DX, Lou J, Zhou Y, Fung KP, Waye MM, Tsui SK, Chan PK, Marks JD, Pang SF, Kan YW Intervirology . Aug 25, 2008 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins Marks James D; Amersdorfer Peter; Geren Isin; Lou Jianlong; Razai Ali; Garcia Maria Consuelos THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS . May 29, 2008 Toxicon Marks James, Garcia Consuelo, Isin N. Geren, Lou Jianlong, Charles M. Forsyth, Fraser Conrad, Wen Weihua, Theresa J. Smith, Brown Jennifer, Al-Saleem Fetweh, Ancharski Denise, Lance L. Simpson, William H. Tepp, Eric A. Johnson and Leonard A. Smith Recombinant antibody potently neutralizes types A, B, and E botulinum neurotoxins by a clearance-driven mechanism . Jan 1, 2008 Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy. Fischer A, Garcia-Rodriguez C, Geren I, Lou J, Marks JD, Nakagawa T, Montal M The Journal of biological chemistry . Nov 20, 2007 Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen. Tang Y, Lou J, Alpaugh RK, Robinson MK, Marks JD, Weiner LM Journal of immunology (Baltimore, Md. : 1950) . Sep 1, 2007 THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS James D Marks, Peter Amersdorfer, Isin Geren, Jianlong Lou, Ali Razai, Consuelos Maria Garcia THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS . Aug 23, 2007 Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Garcia-Rodriguez C, Levy R, Arndt JW, Forsyth CM, Razai A, Lou J, Geren I, Stevens RC, Marks JD Nature biotechnology . Dec 17, 2006 Using phage display to select antibodies recognizing post-translational modifications independently of sequence context. Kehoe JW, Velappan N, Walbolt M, Rasmussen J, King D, Lou J, Knopp K, Pavlik P, Marks JD, Bertozzi CR, Bradbury AR Molecular & cellular proteomics : MCP . Sep 12, 2006 High affinity promotes more effective ADCC by anti-HER2/ neu monoclonal antibodies. Y. Tang, K. Alpaugh, J. Lou, S. Litwin, C. Shaller, G. Adams, J. Marks, L. Weiner Journal of Clinical Oncology . Jun 20, 2006 Enzyme-amplified protein microarray and a fluidic renewable surface fluorescence immunoassay for botulinum neurotoxin detection using high-affinity recombinant antibodies. Varnum SM, Warner MG, Dockendorff B, Anheier NC, Lou J, Marks JD, Smith LA, Feldhaus MJ, Grate JW, Bruckner-Lea CJ Analytica Chimica Acta . May 2, 2006 Isolation of scFvs to in vitro produced extracellular domains of EGFR family members. Horak E, Heitner T, Robinson MK, Simmons HH, Garrison J, Russeva M, Furmanova P, Lou J, Zhou Y, Yuan QA, Weiner LM, Adams GP, Marks JD Cancer biotherapy & radiopharmaceuticals . Dec 1, 2005 Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, Laporte SL, Tepp WH, Bradshaw M, Johnson EA, Smith LA, Marks JD Infection and immunity . Sep 1, 2005 Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. Razai A, Garcia-Rodriguez C, Lou J, Geren IN, Forsyth CM, Robles Y, Tsai R, Smith TJ, Smith LA, Siegel RW, Feldhaus M, Marks JD Journal of molecular biology . Aug 5, 2005 Yeast mating for combinatorial Fab library generation and surface display. Weaver-Feldhaus JM, Lou J, Coleman JR, Siegel RW, Marks JD, Feldhaus MJ FEBS letters . Apr 23, 2004 Antibodies in proteomics II: screening, high-throughput characterization and downstream applications. Bradbury A, Velappan N, Verzillo V, Ovecka M, Chasteen L, Sblattero D, Marzari R, Lou J, Siegel R, Pavlik P Trends in biotechnology . Jul 1, 2003 Antibodies in proteomics I: generating antibodies. Bradbury A, Velappan N, Verzillo V, Ovecka M, Chasteen L, Sblattero D, Marzari R, Lou J, Siegel R, Pavlik P Trends in biotechnology . Jun 1, 2003 Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries. Lou J, Marzari R, Verzillo V, Ferrero F, Pak D, Sheng M, Yang C, Sblattero D, Bradbury A Journal of immunological methods . Jul 1, 2001 In vivo recombination as a tool to generate molecular diversity in phage antibody libraries. Sblattero D, Lou J, Marzari R, Bradbury A Journal of biotechnology . Jun 1, 2001 Applied Biotoxin and Toxicology , Chen Ning Qing, Meng Zhao He( Eds), Lou Jian Long Sterigmatocystin . Jan 1, 2001 Modern Microbiology and Toxicology Jiao Bing Hua, Xie Zheng Yang( Eds) Lou Jian Long Sterigmatocystin . Jan 1, 2000 Voltammetric behavior of mammalian tumor cells and bioanalytical applications in cell metabolism. Feng J, Ci YX, Lou JL, Zhang XQ Bioelectrochemistry and bioenergetics (Lausanne, Switzerland) . Feb 1, 1999 Electromagnetic Biology and Medicine Jun Feng, Ti Yu Gao, Jian Long Lou, Yun Xiang Ci and Zhen Quan Guo Electrochemical Voltammetric Features in Living Tissues of MICE . Jan 1, 1999 Production and characterization of a monoclonal antibody against sterigmatocystin. Lou JL, Guo ZQ, Meng ZH Biomedical and environmental sciences : BES . Mar 1, 1996 Tumor in China Meng Zhao He, Lou Jian Long, Guo Zhen Quan, Tian He Jing, and Liu Zhao Qian The Correlation of Sterigmatocystin and Human Cancer . Jan 1, 1996 [Production and characterization of sterigmatocystin]. Lou J, Wang Y, Wang D, Meng Z Wei sheng wu xue bao = Acta microbiologica Sinica . Oct 1, 1995 [Determination of sterigmatocystin in cancerous tissues, blood and urine in patients with liver and stomach cancer]. Tian H, Lou J, Du C Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] . Sep 1, 1995 [Preparation and identification of monoclonal antibody against sterigmatocystin]. Lou J, Guo Z, Meng Z Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] . Mar 1, 1995 Production and characterization of sterigmatocystin. Lou JL, Meng ZH, Wang DS Biomedical and environmental sciences : BES . Dec 1, 1994 Journal of Hygiene Research Lou Jianlong, Meng Zhaohe Screening of sterigmatocystin-producing aspergillus strains . Jan 1, 1993 Medical Science Abroad Lou Jian Long, Meng Zhao He Progress in Sterigmatocystin Research . Jan 1, 1992 Progress in Sterigmatocystin Research Lou Jian Long, Meng Zhao He Progress in Sterigmatocystin Research . Jan 1, 1992 Chinese Journal of Public Health Lou Jian Long, Zou Kang Nan Production and Application of Antibody against Sterigmatocystin . Jan 1, 1991
